Replacing GHB with GBL in Recreational Settings: A New Trend in Chemsex
- PMID: 30251602
- DOI: 10.2174/1389200219666180925090834
Replacing GHB with GBL in Recreational Settings: A New Trend in Chemsex
Abstract
Background: Recently, Gamma-hydroxybutyrate (GHB) consumption in the recreational setting has been replaced by that of its prodrug Gamma-butyrolactone (GBL), cheaper and easier to obtain due to several legal industrial applications.
Objective: The aim of the present paper was to report the most authoritative literature on the pharmacology and toxicology of GBL, dependence and abuse potential and the related public health issues together with the results of the analyses of several illicit liquid preparations containing GHB/GBL generally sold as "G".
Method: International literature concerning "Gamma-butyrolactone", "GBL" "toxicology", "pharmacology", "abuse", "dependence" and "GHB has been reviewed and liquid preparations containing GHB/GBL analysed by ultra-high performance liquid chromatography coupled to the tandem mass spectrometry validated methodology.
Results: GBL for recreational purposes is orally administered in liquid form and rapidly transformed into GHB by lactonase enzymes present in the blood. As GBL shows a higher lipophilicity than GHB, it is absorbed more quickly, its bioavailability is higher and its effects are faster than those of GHB. Studies on rodents have shown that GBL has a low acute toxicity and only central nervous system depression has been highlighted. GBL abuse potential broadly mimics that of GHB, taking into account that it exerts its effects on the only after conversion into GHB. The analysis of 30 illicit preparations generally sold as "G" highlighted the presence of GBL in all of them at a mean concentration of 760.7 ±91.46 mg/mL (range: 588.5 - 899.3 mg/mL).
Conclusion: GBL currently represents a growing public health issue since the substance is relatively cheaper and easier to obtain than GHB. Improvement and implementation of laws and policies to place GBL under control are needed to limit its diffusion, the eventual health threat for users and its non -negligible abuse liability and dependence risk.
Keywords: abuse; chemsex; dependence; liquid G; γ-butyrolactone (GBL); γ-hydroxybutyrate (GHB)..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
Ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) for determination of GHB, precursors and metabolites in different specimens: Application to clinical and forensic cases.J Pharm Biomed Anal. 2017 Apr 15;137:123-131. doi: 10.1016/j.jpba.2017.01.022. Epub 2017 Jan 9. J Pharm Biomed Anal. 2017. PMID: 28110168
-
Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and its metabolic precursor, gamma-butyrolactone (GBL) in rats.Psychopharmacology (Berl). 2005 Sep;181(3):458-66. doi: 10.1007/s00213-005-0003-x. Epub 2005 Oct 12. Psychopharmacology (Berl). 2005. PMID: 16001124
-
Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.Psychopharmacology (Berl). 2009 Jun;204(3):465-76. doi: 10.1007/s00213-009-1477-8. Epub 2009 Feb 6. Psychopharmacology (Berl). 2009. PMID: 19198808 Free PMC article.
-
Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).Drug Test Anal. 2011 Jul-Aug;3(7-8):417-25. doi: 10.1002/dta.292. Epub 2011 May 6. Drug Test Anal. 2011. PMID: 21548140 Review.
-
Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.CNS Drugs. 2017 Jan;31(1):51-64. doi: 10.1007/s40263-016-0402-z. CNS Drugs. 2017. PMID: 28004314 Review.
Cited by
-
Sex and Cross-Sex Testosterone Treatment Alters Gamma-Hydroxybutyrate Acid Toxicokinetics and Toxicodynamics in Rats.Pharmaceutics. 2024 Jan 21;16(1):143. doi: 10.3390/pharmaceutics16010143. Pharmaceutics. 2024. PMID: 38276513 Free PMC article.
-
Complications Related to Sexualized Drug Use: What Can We Learn From Literature?Front Neurosci. 2020 Nov 27;14:548704. doi: 10.3389/fnins.2020.548704. eCollection 2020. Front Neurosci. 2020. PMID: 33328844 Free PMC article. Review.
-
Identification of Gamma-Butyrolactone in JUUL Liquids.J Anal Toxicol. 2021 Sep 17;45(8):892-900. doi: 10.1093/jat/bkab067. J Anal Toxicol. 2021. PMID: 34100536 Free PMC article.
-
Toxicological Characterization of GHB as a Performance-Enhancing Drug.Front Psychiatry. 2022 Apr 18;13:846983. doi: 10.3389/fpsyt.2022.846983. eCollection 2022. Front Psychiatry. 2022. PMID: 35509886 Free PMC article. Review.
-
γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology.AAPS J. 2021 Jan 8;23(1):22. doi: 10.1208/s12248-020-00543-z. AAPS J. 2021. PMID: 33417072 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials